Delphinus Medical Technologies, Inc., a Michigan-based company, is a spin-off of the Barbara Ann Karmanos Cancer Institute (KCI). The patented technology is a whole breast ultrasound tomography imaging device that provides no radiation, no compression, and is not dependent on operator skills. Delphinus Medical Technologies holds the UST intellectual property, transferred by KCI through a worldwide license to commercialize the SoftVue technology.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/03/13 | $11,000,000 |
Arboretum Ventures Beringea North Coast Technology Investors | undisclosed | |
| 09/10/15 | $39,500,000 | Series C |
Arboretum Ventures Beringea North Coast Technology Investors Waycross Ventures | undisclosed |
| 09/29/22 | $30,000,000 | Series D |
Arboretum Ventures Beringea Hopen Life Science Ventures North Coast Technology Investors Venture Investors Waycross Ventures | undisclosed |
| 08/22/23 | $12,000,000 | Growth |
Trinity Capital Investment | undisclosed |
